Genu Recurvatum Market Report 2026

The genu recurvatum market size has grown strongly in recent years. It will grow from $8.04 billion in 2025 to $8.6 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to orthopedic condition awareness, early rehabilitation practices, availability of bracing solutions, sports injury prevalence, orthopedic surgery development.

The genu recurvatum market size is expected to see strong growth in the next few years. It will grow to $11.49 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to advances in orthopedic devices, personalized bracing solutions, growth of physiotherapy services, aging population, improved diagnostic imaging. Major trends in the forecast period include increased adoption of non-surgical treatment approaches, growing use of custom orthotic bracing, rising demand for physical therapy-based management, expansion of minimally invasive surgical techniques, increased focus on early diagnosis and intervention.

The rising preference for minimally invasive surgeries is expected to drive the growth of the genu recurvatum market in the coming years. Minimally invasive surgeries are medical procedures that involve small or no incisions, utilizing advanced tools such as cameras and specialized instruments to minimize tissue damage, reduce recovery time, and limit scarring compared to traditional open surgeries. The increasing adoption of these procedures is due to their benefits, including shorter recovery periods, lower infection risk, reduced scarring, and shorter hospital stays. Genu recurvatum supports minimally invasive surgeries by enhancing knee alignment and stability, enabling surgeons to operate with greater precision and less tissue disruption. For example, in June 2024, the American Society of Plastic Surgeons, a US-based non-profit organization, reported that minimally invasive procedures grew by 7% in 2023, surpassing the growth rate of surgical procedures by 2%. As a result, the growing preference for minimally invasive surgeries is fueling the genu recurvatum market.

The increasing prevalence of orthopedic disorders is also expected to propel the growth of the genu recurvatum market. Orthopedic disorders are conditions affecting the musculoskeletal system, including bones, joints, muscles, tendons, ligaments, and cartilage. Genu recurvatum can cause knee pain and contribute to knee osteoarthritis and other musculoskeletal conditions. The rising incidence of orthopedic disorders creates demand for treatment, supporting market growth. For instance, in June 2024, the Australian Institute of Health and Welfare (AIHW), an Australia-based government research and statistical agency, reported that osteoarthritis accounted for 2.5% of the total disease burden and 20% of the musculoskeletal disease burden in 2023. Therefore, the growing prevalence of orthopedic conditions is driving the genu recurvatum market.

In April 2023, Nuvasive, Inc., a US-based medical device company, merged with Globus Medical Inc. for an undisclosed amount. This merger brought together two leading firms in the musculoskeletal sector, enhancing their ability to serve physicians and hospital partners by advancing innovation, expanding global medical and commercial reach, and supporting more patients. Globus Medical Inc. is a US-based company that designs, manufactures, and distributes musculoskeletal device solutions and provides revision knee replacement services.

Major companies operating in the genu recurvatum market are Johnson & Johnson MedTech, Stryker Corporation, DePuy Synthes Inc., Zimmer Inc., Smith & Nephew plc, Arthrex, DJO Global Inc., Össur hf, AliMed Inc., Thuasne Ltd., OrthoPro Inc., Performance Health, Trulife Group Limited, Breg Inc., Allard USA, Capstone Orthopedic Inc., BraceAbility, Globus Medical, Medtronic plc, ConMed Corporation, Bioventus, Medacta International, Ottobock SE & Co. KGaA, Exactech Inc.

North America was the largest region in the genu recurvatum market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genu recurvatum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the genu recurvatum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the genu recurvatum market by increasing costs of imported orthopedic braces, rehabilitation equipment, and surgical tools. Hospitals and orthopedic clinics are most affected due to reliance on imported devices. These tariffs raise treatment costs by increasing expenses for corrective bracing, rehabilitation, and surgical intervention. However, they support domestic orthopedic device manufacturing, encouraging local production of braces and rehabilitation equipment.

The genu recurvatum market research report is one of a series of new reports that provides genu recurvatum market statistics, including genu recurvatum industry global market size, regional shares, competitors with a genu recurvatum market share, detailed genu recurvatum market segments, market trends and opportunities, and any further data you may need to thrive in the genu recurvatum industry. This genu recurvatum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Genu recurvatum is a medical condition in which the knee joint hyperextends, causing the knee to bend backward beyond its normal range of motion. The primary treatments for genu recurvatum include strengthening the quadriceps muscles, using a brace to prevent hyperextension, or performing a proximal tibial osteotomy, which adjusts the tibial slope to reduce or correct the condition.

The main types of genu recurvatum are external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD). External rotatory deformity (ERD) is a type of rotational deformity where the foot or leg bone twists outward. Diagnostic methods include magnetic resonance imaging (MRI), X-rays, and other techniques, and the condition can be managed through physical therapy, orthoses, bracing, and surgery. The end users include hospitals, clinics, and other healthcare facilities.

The genu recurvatum market includes of revenues earned by entities by providing services such as physiotherapy and strengthening of calf muscles. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.